You may also like
A Case Series of Recombinant Platelet Factor 4 for Heparin Reversal After Cardiopulmonary Bypass
Our case series demonstrates that heparin anticoagulation was effectively reversed by the administration of rPF4 without serious complications
1 min read
Risks vs. Benefits of the Off-Label Use of Recombinant Factor VIIa in the Cardiac Arena (EP Video)
Alicia Sievert discusses the risks and benefits of off-label use of Recombinant Factor VIIa (23:00 minutes).
1 min read
Impact of Cardiopulmonary Bypass Time on Postoperative Duration of Mechanical Ventilation in Patients Undergoing Cardiovascular Surgeries: A Systemic Review and Regression of Metadata
Cardiopulmonary bypass time appears to affect clinical outcomes adversely and is associated with prolonged MV. Avoiding CPB or limiting it to a minimum may decrease the days of MV required.
1 min read